Galaxy Medicare Limited IPO Details

1. The company is supplying to certain key customers, from whom its derives a significant portion of the company revenues. The loss of any significant customer may have a material and adverse effect on its business and results of operations.

2. The comapny is highly dependent on its suppliers for uninterrupted supply of Raw-Materials. Any shortfall in the supply of the raw materials, or an increase in its raw material costs and other input costs, may adversely affect the pricing and supply of the products with subsequently having an adverse effect on the business, results of operations and financial conditions of the company.

3. The Company, the Directors, and the Promoters is parties to certain legal proceedings. Any adverse decision in such proceedings may have adverse effect on its business, prospects, results of operations and financial condition.

4. There have been instances of delay in filing of Goods and Service Tax (GST) returns, Employee State Insurance (ESI) Returns, return of Tax Deducted at Source (TDS) dues and in payment of Provident Fund dues.

5. Inventories and trade receivables form a major part of the current assets. Failure to manage the company inventory and trade receivables could has an adverse effect on its net sales, profitability, cash flow and liquidity.

6. The company is dependent on its promoters and senior management and other key personnel, and the loss of, or its inability to attract or retain, such persons could affect of the business, results of operations, financial condition and cash flows.

7. The Proliferation of Look-alike Products in the Market poses a risk on its reputation and brand name.

8. The company derives a substantial amount of its revenue from exports and the exports is exposed to potential financial, economic, political and other risks of international markets.

9. Its cost of production is exposed to fluctuations in the prices of the major raw material.

10. Any delay, interruption or reduction in the supply of raw materials to manufacture of the products may adversely affect its business, results of operations, cash flows and financial condition.